DelveInsight’s Epilepsy pipeline report depicts a robust space with 75+ active players working to develop 90+ pipeline ...

Shane Van Gisbergen was not to be denied Sunday in Mexico City, putting on an incredible run in the closing laps of the event to win the Viva Mexico 250, his second career win in the NASCAR Cup ...

Treatment with cenobamate may reduce seizure frequency among patients with drug-resistant epilepsy after 3 months.

Cephalexin is a prescription drug used to treat certain infections. Learn about the drug’s dosages, forms, strengths, and more.

Paladin Pharma is pleased to announce the successful completion of negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for the public funding of XCOPRI® (cenobamate tablets) as ...

At AAN 2025, SK Life Science will highlight the impact of cenobamate on RNS epileptiform events. A retrospective, multicenter, observational, 24-week study among 37 patients with uncontrolled ...

Dong-A ST signed a technology transfer contract for the production of finished products (DP) for the supply of cenobamate in 30 countries with SK Biopharm in January last year.

SK Bioscience stated that this sales achievement is significant as it marks the first annual surplus achieved solely through Cenobamate sales without the assistance of one-time revenues such as ...

Cenobamate is an antiseizure medication (ASM) discovered and developed by SK Biopharmaceuticals and SK Life Science. Cenobamate reduces neuronal excitability through a unique dual mechanism of action, ...